DZ Bank’s Forward Pharma A/S American Depositary Shares FWP Stock Holding History

DZ Bank’s Portfolio FWP Stock Details FWP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-5,746	Closed	-$87K	–	1174
2018 Q1	$87K	Buy	+5,746	New	+$140K	﹤0.01%	1017

Other funds holding FWP

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

DZ Bank's FWP Position: Q2 2018 in Review

DZ Bank sold out of Forward Pharma A/S American Depositary Shares (FWP) in Q2 2018, closing a stake of 5,746 shares — an estimated $87K sold.

DZ Bank first reported a position in FWP in Q1 2018 and held it in 1 quarter. The position peaked at $87K in Q1 2018. 13 funds tracked by Wall St. Rank hold FWP as of Q2 2018.

DZ Bank reported no remaining Forward Pharma A/S American Depositary Shares position as of Q2 2018 after selling out during the quarter.
DZ Bank sold 5,746 Forward Pharma A/S American Depositary Shares shares in Q2 2018, an estimated $87K.
DZ Bank first reported a position in Forward Pharma A/S American Depositary Shares in Q1 2018 and held it in 1 quarter.
DZ Bank's Forward Pharma A/S American Depositary Shares position peaked at $87K in Q1 2018.
13 funds tracked by Wall St. Rank held Forward Pharma A/S American Depositary Shares as of Q2 2018.

Based on DZ Bank's 13F filing for Q2 2018, filed 14 Aug 2018.